FDA Admits Cannabis Fails Old Medical-Value Test as DEA Hearing Sharpens Rescheduling Fight
The second day of the Drug Enforcement Administration's administrative hearing on cannabis rescheduling turned confrontational in the most substantive way possible: opponents of marijuana reform